Sign in or create an account to add this stock to your watchlist.
About Redpoint Bio (OTCMKTS:RPBC)
Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania.
Industry, Sector and Symbol
Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:RPBC
CUSIPN/A
Phone215-456-2312
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares79,920,000
Redpoint Bio (OTCMKTS:RPBC) Frequently Asked Questions
What is Redpoint Bio's stock symbol?
Redpoint Bio trades on the OTCMKTS under the ticker symbol "RPBC."
Who are some of Redpoint Bio's key competitors?
Some companies that are related to Redpoint Bio include IQVIA (IQV), Incyte (INCY), ICON (ICLR), EXACT Sciences (EXAS), Exelixis (EXEL), PRA Health Sciences (PRAH), Charles River Laboratories Intl. (CRL), Syneos Health (SYNH), BTG (BTGGF), Intrexon (XON), Medpace (MEDP), National Research (NRCIB), National Research (NRCIA), Sorrento Therapeutics (SRNE) and Pieris Pharmaceuticals (PIRS).
Who are Redpoint Bio's key executives?
Redpoint Bio's management team includes the folowing people:
- Dr. R. Kyle Palmer Ph.D., Sr. Director of Discovery Research
Has Redpoint Bio been receiving favorable news coverage?
News stories about RPBC stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Redpoint Bio earned a daily sentiment score of 0.09 on Accern's scale. They also gave news headlines about the company an impact score of 47.80 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of Redpoint Bio?
Shares of RPBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Redpoint Bio's stock price today?
One share of RPBC stock can currently be purchased for approximately $0.0012.
How big of a company is Redpoint Bio?
Redpoint Bio has a market capitalization of $100,000.00.
How can I contact Redpoint Bio?
Redpoint Bio's mailing address is 7 GRAPHICS DRIVE, EWING NJ, 08628. The company can be reached via phone at 215-456-2312.
MarketBeat Community Rating for Redpoint Bio (RPBC)
MarketBeat's community ratings are surveys of what our community members think about Redpoint Bio and other stocks. Vote "Outperform" if you believe RPBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPBC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Redpoint Bio (OTCMKTS:RPBC) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 5/23/2016 forward)
Redpoint Bio (OTCMKTS:RPBC) Earnings History and Estimates Chart
Redpoint Bio (OTCMKTS RPBC) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/16/2011 | Q1 2011 | | ($0.01) | | | View | N/A |  |
| 3/4/2011 | Q4 2010 | ($0.02) | ($0.01) | | | View | N/A | |
| 11/9/2010 | Q3 2010 | ($0.02) | ($0.02) | | | View | N/A | |
| 8/13/2010 | Q2 2010 | ($0.02) | ($0.02) | | | View | N/A | |
| 5/14/2010 | Q1 2010 | | ($0.02) | | | View | N/A | |
| 3/29/2010 | Q4 2009 | | ($0.02) | | | View | N/A | |
| 11/12/2009 | Q3 2009 | | ($0.03) | | | View | N/A | |
| 8/13/2009 | Q2 2009 | | ($0.03) | | | View | N/A | |
| 5/14/2009 | Q1 2009 | | ($0.03) | | | View | N/A | |
| 3/26/2009 | Q4 2008 | | ($0.02) | | | View | N/A | |
| 11/7/2008 | Q3 2008 | ($0.03) | ($0.03) | | | View | N/A | |
| 8/8/2008 | Q2 2008 | ($0.03) | ($0.03) | | | View | N/A | |
| 5/9/2008 | Q1 2008 | | ($0.03) | | | View | N/A | |
| 3/10/2008 | Q4 2007 | ($0.02) | ($0.02) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Redpoint Bio (OTCMKTS:RPBC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Redpoint Bio (OTCMKTS RPBC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 11.51%
Redpoint Bio (OTCMKTS RPBC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Redpoint Bio (OTCMKTS RPBC) News Headlines
| Source: |
|
No headlines for this company have been tracked by MarketBeat.com
Redpoint Bio (OTCMKTS:RPBC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Redpoint Bio (OTCMKTS RPBC) Stock Chart for Wednesday, May, 23, 2018
Loading chart…
